Category: Science


Dr. Marc Hurlbert Joins MRA as Chief Science Officer

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 20 November 2018 In Science

Dr. Marc Hurlbert has built his career advancing medical research in support of patients. Now, as of this month, he will translate his skills, relationships, and enthusiasm to achieving our mission of ending death and suffering due to melanoma as MRA’s Chief Science Officer.

Read More


When Astrophysics & Melanoma Collide

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 16 November 2018 In Science

Using lessons, processes, and tools from the field of astrophysics, Dr. Taube is studying melanoma in all new ways.

Read More


Improving the Lives of Melanoma Survivors

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 15 October 2018 In Prevention, Science

Melanoma survivors are at a 9-fold increased risk of developing another melanoma. Unfortunately, 20% of survivors reported a sunburn in the past year and 10% intentionally went outside for a tan – both strong predictors of inappropriate sun exposure.

Read More


Older Patients Do Better on Immunotherapy

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 8 October 2018 In Science, Treatment

In Dr. Weeraratna's study, older patients did better on immunotherapy than younger patients. This surprising result is the opposite of what was expected.

Read More


Using Zebrafish to Shed New Light on Melanoma

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 29 August 2018 In Science

Dr. Liz Patton, a MRA-funded cancer researcher at the Medical Research Council Human Genetics Unit at the University of Edinburgh, is fascinated by learning how things work. Patton has focused her research on better understanding how melanocytes – the cells in our skin that provide us our coloring – develop, divide, migrate, and in some unfortunate circumstances, proliferate uncontrollably turning into melanoma. Her work is providing critical insight into the origin of melanoma and what spurs melanoma to spread throughout the body.

Read More


Maintaining the Pace of Melanoma Innovation in the Era of an Evolving Standard of Care

10 August 2018 In Science, Treatment

There is no doubt that treatments for metastatic melanoma have changed dramatically in the decade since MRA’s founding in 2007. How do we keep up the momentum?

Read More


Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 18 July 2018 In Allies & Partnerships, Melanoma Stories, News, Science, Treatment

When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.

Read More


Applying AI to Melanoma Detection

5 July 2018 In Prevention, Science

Is AI the future of detecting melanoma early, when it is easiest to cure?

Read More


Making the Most Out of Immunotherapy

11 June 2018 In Science, Treatment

Learn what MRA-funded investigators are doing to optimize immunotherapy for patients.

Read More


We’ve Teamed Up with the American Cancer Society

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 7 June 2018 In Allies & Partnerships, Science, Treatment

American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.

Read More


Login

×